Point-of-care of the future, when and where you need it. iViz delivers fast and improved
patient care with superior clarity, mobility, and unprecedented connectivity.
BOTHELL, WA., September 15, 2015 – FUJIFILM SonoSite Inc., a specialist in designing cutting-edge ultrasound tools and world-leading education for access to point-of-care visualization, today announced CE mark for its newest Point-of-Care solution: the iViz. Inspired by clinicians, the iViz is a new platform that augments the value of ultrasound for clinical users from hospital settings to clinics in remote villages with the ability to perform ultrasound when and where it is needed
“FUJIFILM SonoSite delivers a powerful and valuable solution to the market with the launch of iViz. It is a revolutionary tool that reaches new levels of mobility, image performance, and connectivity,” said Masayuki Higuchi, president and CEO of FUJIFILM SonoSite, Inc. “Clinicians will now have access to technology that can be used on-the move, in-the-field or on-the ground."
The iViz represents the next generation architecture and platform for Fujifilm's integration of ultrasound with medical IT. The iViz goes beyond traditional ultrasound abilities and provides clinicians with seamless access to patient vitals, online applications and learning resources. It also integrates with hospital IT and EMR systems to obtain patient demographics and submit reports, and connects securely with cloud services for sharing studies with remote providers for near-time assessments.
The iViz is lightweight and specifically designed for emerging point-of-care settings where there is need for a highly accessible and mobile solution. It features a high resolution seven-inch display touchscreen, a wide dynamic range over a large viewing angle with high definition vibrant color flow images, Wi-Fi capabilities, Bluetooth connectivity, and interface ports for USB, HDMI, and audio.
In addition to high resolution 2D imaging, the system supports M-Mode and Color Velocity Doppler. The iViz is available with a P21v phased array 5MHz transducer, and features proprietary software technologies: SonoHD2 Imaging Technology, and SonoADAPT Tissue Optimization Technology.
For more information about FUJIFILM SonoSite, please visit: www.sonosite.com.
FUJIFILM SonoSite, Inc., is the innovator and world leader in bedside and point-of-care ultrasound, and an industry leader in ultra high-frequency micro-ultrasound technology. Headquartered near Seattle, the company is represented by 26 subsidiaries and a global distribution network in over 100 countries. SonoSite’s portable, compact systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care. For more information, go to: www.sonosite.com.
FUJIFILM Holdings Corporation, Tokyo, Japan brings continuous innovation and leading-edge products to a broad spectrum of industries, including: healthcare, with medical systems, pharmaceuticals and cosmetics; graphic systems; highly functional materials, such as flat panel display materials; optical devices, such as broadcast and cinema lenses; digital imaging; and document products. These are based on a vast portfolio of chemical, mechanical, optical, electronic, software and production technologies. In the year ended March 31, 2014, the company had global revenues of $23.9 billion, at an exchange rate of 102 yen to the dollar. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com.
All product and company names herein may be trademarks of their registered owners.